Levi & Korsinsky, LLP announces that an SMFR class action lawsuit has been filed on behalf of investors who purchased Sema4 Holdings, Corp. (SMFR) securities between March 14, 2022, and August 15, 2022. For more on the SMFR Lawsuit please contact us today.

According to the Sema4 Holdings, Corp. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) there was a significant risk that Sema4 would reverse a material amount of previously recognized revenue that it could not recoup from third-party payors; (2) the Company was experiencing declining selling prices for its reproductive health segment; (3) as a result of the foregoing, Sema4’s financial results would be adversely affected; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and lacked a reasonable basis.

TO LEARN MORE ABOUT THE SMFR CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Sema4 Holdings, Corp. you have until November 7, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com